Perlan Therapeutics Inc (AKA: CFY Biomedicals Inc) Profile last edited on: 7/26/18
CAGE: 1NEP4
UEI:
Business Identifier: Protein-based therapeutics and diagnostic products 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 52
County: San Diego
Congr. District: 52
County: San Diego
Public Profile
Formerly dba CFY Biomedicals, Inc, Perlan Therapeutics, Inc.had been in the bsuiness of developing protein-based pharmaceuticals. The firm's preclinical testing products include CFY196, a daily nasal spray for prevention and treatment of the common cold. The company's proprietary Multi-Valence technology platform had been the basis for the development of cost-effective protein-based therapeutics and diagnostic products that are characterized by increased binding avidity. Following a complex legal battle is 2010, firm seems to have ceased operations.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
10-14Revenue Range
1M-1.5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2003 | 2 | NIH | $908,898 | |
| Project Title: Affinity Enhancement of a Humanized Anti-ICAM Antibody | ||||
| 2001 | 1 | NIH | $106,542 | |
| Project Title: Tetravalent Humanized Anti-ICAM for Rhinovirus Infection | ||||
Key People / Management
Sterling C Johnson -- President
Many Yu -- Former President
Many Yu -- Former President
